112 related articles for article (PubMed ID: 16311241)
1. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation.
Wagner TM; Mullally JE; Fitzpatrick FA
J Biol Chem; 2006 Feb; 281(5):2598-604. PubMed ID: 16311241
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modification of serine/threonine kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
J Biol Chem; 2012 Dec; 287(50):42400-6. PubMed ID: 23086944
[TBL] [Abstract][Full Text] [Related]
3. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.
Mullally JE; Moos PJ; Edes K; Fitzpatrick FA
J Biol Chem; 2001 Aug; 276(32):30366-73. PubMed ID: 11390388
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
[TBL] [Abstract][Full Text] [Related]
5. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
6. LKB1 kinase: master and commander of metabolism and polarity.
Spicer J; Ashworth A
Curr Biol; 2004 May; 14(10):R383-5. PubMed ID: 15186763
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Δ
Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.
Musiek ES; Gao L; Milne GL; Han W; Everhart MB; Wang D; Backlund MG; DuBois RN; Zanoni G; Vidari G; Blackwell TS; Morrow JD
J Biol Chem; 2005 Oct; 280(42):35562-70. PubMed ID: 16100121
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress.
Kondo M; Oya-Ito T; Kumagai T; Osawa T; Uchida K
J Biol Chem; 2001 Apr; 276(15):12076-83. PubMed ID: 11278531
[TBL] [Abstract][Full Text] [Related]
12. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.
Straus DS; Glass CK
Med Res Rev; 2001 May; 21(3):185-210. PubMed ID: 11301410
[TBL] [Abstract][Full Text] [Related]
13. Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis.
Shan T; Xu Z; Liu J; Wu W; Wang Y
J Cell Physiol; 2017 Oct; 232(10):2653-2656. PubMed ID: 28067405
[TBL] [Abstract][Full Text] [Related]
14. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes.
Stamatakis K; Pérez-Sala D
Ann N Y Acad Sci; 2006 Dec; 1091():548-70. PubMed ID: 17341644
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.
Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2403685121. PubMed ID: 38743625
[TBL] [Abstract][Full Text] [Related]
16. The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake.
Wang F; Yang X; Lu Y; Li Z; Xu Y; Hu J; Liu J; Xiong W
J Biol Chem; 2019 Jul; 294(27):10415-10427. PubMed ID: 31113861
[TBL] [Abstract][Full Text] [Related]
17. The LKB1/AMPK polarity pathway.
Mirouse V; Billaud M
FEBS Lett; 2011 Apr; 585(7):981-5. PubMed ID: 21185289
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
19. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
[TBL] [Abstract][Full Text] [Related]
20. LKB1 Represses ATOH1 via PDK4 and Energy Metabolism and Regulates Intestinal Stem Cell Fate.
Gao Y; Yan Y; Tripathi S; Pentinmikko N; Amaral A; Päivinen P; Domènech-Moreno E; Andersson S; Wong IPL; Clevers H; Katajisto P; Mäkelä TP
Gastroenterology; 2020 Apr; 158(5):1389-1401.e10. PubMed ID: 31930988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]